Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety Trial of Enzalutamide in Combination With PDMX1001/Niclosamide in Castration-Resistant Prostate Cancer (CRPC)

NCT03123978 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT03123978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03123978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety Trial of Enzalutamide in Combination With PDMX1001/Niclosamide in Castration-Resistant Prostate Cancer (CRPC)
Lead sponsor
University of California, Davis
Phase
Phase 1
Overall status
Completed
Start date
January 9, 2017
Completion date
April 19, 2022
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate carcinoma, recurrent prostate carcinoma, stage iv prostate cancer